Johnson & Johnson JNJ

$273.20 -2.00 (-0.73%)

Valuation

Market cap
652,477,312,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
PE ratio
25.23
Forward PE
24.17
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
8,969,220
Avg volume
6,922,038
Day's range
$273.13 – $282.02
Shares out
2,407,310,000
Stochastic %K
89%
Beta
0.21
Analysts
Strong Sell
Price target
$281.88

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

thatsolardude365 Oct 30, 9:44 PM
$JNJ: no talc claim portal exists. With MDL 2738 still in mediation and no global deal, ovarian cancer cases move only as individual suits after attorney review. J&J denies the allegations. Open Class Actions.
0 replies
KingTrades09 Oct 30, 9:37 PM
$IBM still holding $JNJ sold today at 280 $WMT sold half backed each one with a chart
0 replies
DidYouReadThis Oct 30, 7:07 PM
$NVS $BAYRY $RHHBY $JNJ Any other #FDA approvals that you would say were big ones for 2026 to add to the #watchlist for 2027?
0 replies
KingTrades09 Oct 30, 6:04 PM
$IBM $JNJ $WMT These three paid on calls this week and puts on the indices paid yesterday and today..
0 replies
Stocktwits52wHighs Oct 30, 3:16 PM
$JNJ printed a new 52-week high today
0 replies
gayforsanjay Oct 30, 2:56 PM 1 replies
Baddb Oct 30, 2:28 PM
$JNJ 👀😂😈
0 replies
Baozun13 Oct 30, 12:41 PM
$JNJ why did this suddenly double is there any fundamental change or is this just a sign of the times -
1 replies